advanced search
Mark Tunkel
Global Category Director, Services
Nemera

Is this your profile?

About

Mark Tunkel is Global Category Director, Services at Nemera. He was previously a partner at Insight Product Development, which was acquired by Nemera in 2019 and became the Insight Innovation Center. With more than 20 years of global business development experience and a deep understanding of the marketplace challenges and trends impacting the pharma industry, Mr Tunkel has advised many of the world’s leading companies on their product development and innovation strategies, with an emphasis on driving realisation and the most favourable business outcomes.

Contributions

WEARABLES
SYMBIOZE®: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE
Cécile Gross and Mark Tunkel discuss the how Nemera's on-body injector platform – Symbioze® – has been developed by drawing on a combination of lessons learned from the history of injection devices and the company’s extensive experience developing drug delivery devices for the parenteral route.

More contributions

INJECTION
ADDRESSING DIABESITY WITH PEN INJECTOR PLATFORMS
 Cécile Gross and Mark Tunkel discuss the variety of pen injector platforms to meet the different needs of diabetes patients.
CONNECTIVITY
HOW TO NAVIGATE A COMPLEX CONNECTIVITY ENVIRONMENT
Pascal Dugand, Cécile Gross and Mark Tunkel consider the complexity of the landscape for connected devices and demonstrate how a balance can be achieved between patient needs, technology and the cost of integrating this technology into a device.
WEARABLES
CHRONIC PATIENTS AT THE CENTRE OF LARGE-VOLUME SC DELIVERY WITH A SUSTAINABLE ON-BODY INJECTOR
Cécile Gross and Mark Tunkel discuss the role of patient-centricity in the development of Nemera’s sustainable on-body injector platform.
INJECTION
ADDRESSING PEPTIDE THERAPEUTICS WITH A VERSATILE PEN PLATFORM
Cécile Gross and Mark Tunkel discuss the rising demand in peptide therapeutics and how Nemera’s PenVario pen injector platform, coupled with Nemera’s end-to-end service offering, has been designed to help pharma partners achieve success in this sector.
#136_2022_Aug_Nemera_Featured
INDUSTRIALISATION
HOLISTIC DEVELOPMENT & INDUSTRIALISATION OF DRUG DELIVERY DEVICES & COMBINATION PRODUCTS
Mark Tunkel and Niyati Sapatnekar discuss Nemera’s holistic approach to development and industrialisation.
PULMONARY
LEVERAGING HUMAN FACTORS TO DEVELOP PATIENT-CENTRIC INHALERS
Raphaële Audibert, Mark Tunkel and Manuela Basso look at the role patient-centricity has to play in the development of inhalers to treat chronic respiratory diseases.
INJECTION
LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME
Séverine Duband and Mark Tunkel discuss the importance of device optimisation to increase patient safety during self-administration of medication.
EXPERT VIEW
USER-CENTRED DEVICE CONNECTIVITY
Mark Tunkel and Carolyn Rose discuss the benefits of taking a user-needs approach, and mapping the patient journey, in a connectivity strategy.
EXPERT VIEW
PLATFORM DEVICES AND THE PATIENT JOURNEY
Mark Tunkel discusses the benefits of mapping the patient journey when looking to select a platform device for a new drug-device combination product.
EXPERT VIEW
WHY SUCCESS IN DRUG DELIVERY IS NOT JUST ABOUT THE DEVICE
Mark Tunkel explains how companies developing and marketing inhalable pharmaceuticals can explore other strategies to improve patient outcomes over and above what the drug and device can achieve.
EXPERT VIEW
LEVERAGING NEEDS-CHARACTERISATION TO FUEL SMARTER DESIGN
Mark Tunkel and Craig Scherer discuss how needs-characterisation is becoming an essential part of combination product strategy in an increasingly competitive market.
Top